Abstract
Friedreich Ataxia (FA) is a progressive and systemic neuromuscular disease, affecting ∼1:20,000 births, characterized by ataxia, scoliosis, and loss of ambulation, and other clinical manifestations. Our aim was to characterize real-world healthcare resource use (HCRU) among commercially insured patients with FA in the United States (US) and compare that to non-FA patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
